https://a-485inhibitor.com/man....ufacture-associated-
Individuals had been 79 army veterans (91% male; 38% African American [AA] and 62% White) with current SUD/PTSD who were randomized to receive Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged publicity (COPE) or Relapse Prevention (RP). Main results included substance use and self-reported and clinician-rated PTSD signs. At standard, AA individuals were somewhat older, reported higher compound and alcoholic beverages usage, and tended to